Navigation Links
NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium
Date:10/6/2008

will each receive up to $172.5 million for achieving pre-agreed clinical, regulatory and commercialisation targets for both the monotherapy and combination product. These potential milestones total up to $375 million. In addition, royalties on product sales will be paid for the monotherapy and the combination product. If a third combination product is developed by Novartis, using NVA237, further milestones and royalties will be payable.

About COPD

COPD is a chronic obstruction of the airways which in the developed world is caused primarily by smoking. Symptoms include chronic bronchitis and/or emphysema which slowly progress and eventually lead to a largely irreversible loss of lung function. COPD is currently the fourth most common cause of death and by 2030 is predicted to become the third most common cause of death and the fourth most important disability causing illness. The total financial burden of lung disease in Europe amounts to nearly EUR102 billion with COPD contributing almost one half of this figure. Around three-quarters of patients with advanced COPD are unable to perform normal everyday activities. The market for COPD drug therapy was estimated to be worth around $5.7 billion in 2007 with a compound average growth rate of 19% over the preceding 5 years. Further significant growth can be anticipated as a result of better diagnosis and treatment and the introduction of high value new products.

About Sosei

Sosei Group is a leading international biopharmaceutical company with significant expertise in product discovery and development. It has established a reduced risk business model primarily upon identifying new uses for established drugs and exploiting its unique position within Japanese, European and North American pharmaceutical markets by acquiring compounds from, and bringing compounds into, Japan.

For further information about Sosei, please visit http://www.sosei.com'/>"/>

SOURCE Sosei Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
2. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
3. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
4. Pharmaleads Lead Candidate for Pain, PL37, Enters Phase I
5. Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients
6. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
7. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
8. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
9. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
10. Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
11. Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... BERKELEY, Calif. and COPENHAGEN, ... CMC Biologics, Inc. , a global leader in clinical ... proteins, announced today that, as part of its global ... of its North American manufacturing facility in ... single-use Bioreactor 6Pack™ facility.  The Bioreactor 6Pack™ configuration consists ...
(Date:6/30/2015)... , June 30, 2015 ... as advisor to Chip-Man Technologies Oy (CMT) on its ... The assets relate to CMTs world leading capabilities in ... the latest in a series of successful global deals ... clients. Fintan Walton , CEO, PharmaVentures, ...
(Date:6/29/2015)... Diagnostics was honored at the 2015 IEEE Spectrum ... Award. IEEE President and CEO, Howard E. Michel , ... award to Principal Scientist Martina Medkova , Ph.D., on ... 2015, at the historic Waldorf Astoria hotel in ... spent more than 3 years as a Daktari scientist developing ...
Breaking Medicine Technology:CMC Biologics Expands GMP Manufacturing Capacity in the United States 2CMC Biologics Expands GMP Manufacturing Capacity in the United States 3PharmaVentures Completes M&A Deal for Technology in the Stem Cell & Regenerative Medicine Sector 2Daktari Honored with IEEE Spectrum Award 2
(Date:6/30/2015)... , ... June 30, 2015 , ... ... customers. As a subcontractor, ESSC ranked as one of their top 20 installing ... the last quarter of 2014. Providers are based on timeliness, service, installation, paperwork ...
(Date:6/30/2015)... ... , ... Ticket Down is a reliable source for cheap tickets for Journey at the ... band has been packing venues for years and they are one of the most beloved ... in their career. While Journey is known for their all-around great sound, fans of ...
(Date:6/30/2015)... ... June 30, 2015 , ... The board certified otolaryngologists ... design’ website to inform potential sinus surgery patients about ear, nose, and throat ... information about a wide variety of ENT issues including hearing loss, ear infections, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Earlier this month Wound ... Medicine Course. Clinicians from WCA partnering hospitals across the country, met in Anaheim, ... care and hyperbaric medicine education and training is something that is never complete. ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... YouTube video, “Fireside Convalescent Care Center.” The video informs community members of Fireside’s ... continually seeing the need for those seeking care to be well informed and ...
Breaking Medicine News(10 mins):Health News:Electronic Security Specialists (E.S.S.C. Inc) Awarded Top Service Provider Award By Monitronics 2Health News:Journey Tickets at The Stadium of Fire at Lavell Edwards Stadium in Provo, Utah: Ticket Down Slashes Ticket Prices for Journey on the 4th of July in Provo 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 3Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Fireside Convalescent Hospital Proves Itself as a Leading Care Center in New Video 2
... breast cancer patient has to pay thousands of dollars as ... case against the doctor//. Doctor Robert Newton is the family ... case for negligent treatment as they feel that the doctor ... case against Dr. Newton for a compensation of $2million for ...
... seen when Pharma major Wockhardt limited (Thiruvananthapuram) in association with ... vaccine//, marketed the latest vaccine for Hepatitis A. ,Hepatitis ... to be taken to curb the spread of the disease. ... period of almost a month and spreads to humans through ...
... arguments can delay wound healing according to a new study ... New Scientist//. ,.,Researchers at Ohio State University College of ... about half hour daily can have delayed wound healing at ... also cause reduced body immunity. ,42 married couples whose ...
... stabilize the rates of HIV by the year 2020 has ... HIV infected individuals on a monthly basis//. It has also ... below 0.3 percent by 2010. The current projected population of ... recent government decision, poor HIV carriers living in communities are ...
... Her-2/neu positive was helped by her Wangaratta community to ... costs her more than $70,000.// The fund was raised ... could help her to buy Herceptin drug for one ... to chemotherapy and anti-estrogen therapy such as tamoxifen and ...
... novel finding that love and addiction may go hand ... physiological effects manifested as a result of dopamine release// ... than a simulation of the effects observed following drug ... and drug abuse leaves the user with an insatiable ...
Cached Medicine News:Health News:‘Marriage Squabbles’ bad for both Emotional and Physical Wound 2Health News:Love And Drug Addiction Share The Same Chemistry 2
... Dermalinfusion is the only treatment ... a topical dermaceutical while exfoliating ... all skin types and addresses ... conditions including hyperpigmentation, acne, photodamage, ...
... practices that require an increased energy rating ... versatility of the Clareon System enables you ... that would typically require multiple cosmetic lasers. ... obsolescence because the Clareon is specifically designed ...
Disposable. Sterile Suction Tubing....
Bi-phasic peristaltic infusion pump for tumescent work....
Medicine Products: